Applications focused on ICP/MS - page 1
ICP-MS ELEMENTAL IMPURITY ANALYSIS IN PHARMACEUTICALS
Others
| 2017 | Agilent Technologies
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Analysis of Elemental Impurities in Synthetic Oligonucleotides by ICP-MS In compliance with USP <232>/<233> and ICH Q3D(R2)/Q2(R1)
Posters
| 2024 | Agilent Technologies (ASMS)
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Determination of Extractable and Leachable Elements Using ICP-MS
Applications
| 2022 | Agilent Technologies
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Determining Elemental Impurities in Pharmaceutical Ingredients using ICP-MS
Applications
| 2021 | Agilent Technologies
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1)
Applications
| 2022 | Agilent Technologies
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Screening Analysis of 24 Elemental Impurity Elements in Drugs Using ICPMS-2040/2050
Applications
| 2024 | Shimadzu
ICP/MS
Industries
Pharma & Biopharma
Proposed new ICH and USP methods for elemental impurities: The application of ICP-MS and ICP-OES for pharmaceutical analysis
Technical notes
| 2014 | Agilent Technologies
ICP/MS, ICP-OES
Instrumentation
ICP/MS, ICP-OES
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Analysis of Artificial Tear Eye Drops For Elemental Impurities
Applications
| 2022 | Agilent Technologies
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Analysis of Elemental Impurities in Medium- chain Triglycerides According to USP
Applications
| 2022 | Shimadzu
ICP/MS
Industries
Pharma & Biopharma
Analysis of Pharmaceutical Raw Materials Compliant with ICH Q3D Guideline Using ICP-MS with Collision/Reaction Mode
Applications
| 2025 | Shimadzu
ICP/MS
Industries
Pharma & Biopharma